Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Clinical trial NCT02523014 · RECRUITING

Trial details

NCT number: NCT02523014
Sponsor: Alliance for Clinical Trials in Oncology
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Intracranial Meningioma Recurrent Meningioma NF2 Gene Mutation

Start date: 2015-09-28
Primary completion: 2027-01-01
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.